1 arteries, increased vascular resistance, and right-sided heart failure.

2 nts with pulmonary vascular disease who have right-sided heart failure.

3  in pulmonary vascular resistance leading to right-sided heart failure.

4  Avoidance of the clinical syndrome of acute right-sided heart failure after heart transplantation is

5 nsable, especially in patients with signs of right-sided heart failure and those with congenital hear

6 s strongly associated with manifestations of right-sided heart failure and with long-term adverse out

7 right ventricular hypertrophy, decompensated right-sided heart failure, and death.

8 ommon clinical presentation of predominantly right-sided heart failure, in the absence of significant

9       While the systemic character of PH and right-sided heart failure is often neglected or underest

10 nding of the systemic consequences of PH and right-sided heart failure on multiple organ systems, foc

11 ent late in their disease course with severe right-sided heart failure, pulmonary hypertension, and l

12 ve and validate a novel risk score for early right-sided heart failure (RHF) after left ventricular a

13 , continuous flow can predispose patients to right-sided heart failure (RHF) and aortic insufficiency

14                                 The EUROMACS Right-Sided Heart Failure Risk Score was developed to pr

15                The main consequence of PH is right-sided heart failure which causes a complex clinica